[go: up one dir, main page]

DE60025260D1 - Verwendung des sekretorischen leukozytären Proteasehemmers für Keloide und Narben - Google Patents

Verwendung des sekretorischen leukozytären Proteasehemmers für Keloide und Narben

Info

Publication number
DE60025260D1
DE60025260D1 DE60025260T DE60025260T DE60025260D1 DE 60025260 D1 DE60025260 D1 DE 60025260D1 DE 60025260 T DE60025260 T DE 60025260T DE 60025260 T DE60025260 T DE 60025260T DE 60025260 D1 DE60025260 D1 DE 60025260D1
Authority
DE
Germany
Prior art keywords
keloids
scars
protease inhibitor
secretory leucocyte
leucocyte protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60025260T
Other languages
English (en)
Other versions
DE60025260T2 (de
Inventor
Minoru Ueda
Yukio Sumi
Kenichiro Hata
Hisako Muramatsu
Takashi Muramatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tissue Engineering Co Ltd
Original Assignee
Japan Tissue Engineering Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tissue Engineering Co Ltd filed Critical Japan Tissue Engineering Co Ltd
Publication of DE60025260D1 publication Critical patent/DE60025260D1/de
Application granted granted Critical
Publication of DE60025260T2 publication Critical patent/DE60025260T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE60025260T 1999-10-26 2000-10-25 Verwendung des sekretorischen leukozytären Proteasehemmers für Keloide und Narben Expired - Fee Related DE60025260T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30431899 1999-10-26
JP30431899 1999-10-26
PCT/JP2000/007476 WO2001030389A1 (fr) 1999-10-26 2000-10-25 Inhibiteurs de contraction de blessure

Publications (2)

Publication Number Publication Date
DE60025260D1 true DE60025260D1 (de) 2006-02-02
DE60025260T2 DE60025260T2 (de) 2006-08-24

Family

ID=17931592

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025260T Expired - Fee Related DE60025260T2 (de) 1999-10-26 2000-10-25 Verwendung des sekretorischen leukozytären Proteasehemmers für Keloide und Narben

Country Status (6)

Country Link
US (1) US6984621B1 (de)
EP (1) EP1234581B1 (de)
JP (1) JP4610832B2 (de)
AU (1) AU7957700A (de)
DE (1) DE60025260T2 (de)
WO (1) WO2001030389A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001241913A1 (en) * 2000-03-01 2001-09-12 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for wound treatment
GB0309064D0 (en) 2003-04-22 2003-05-28 Univ Manchester Modified peptides and their uses
GB0605949D0 (en) * 2006-03-24 2006-05-03 Quest Int Serv Bv Milk product for skin treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871956A (en) * 1984-12-06 1999-02-16 Amgen Inc. Recombinant methods for production of serine inhibitors and DNA sequences useful for same
WO1992006706A1 (en) 1990-10-16 1992-04-30 John Lezdey Treatment of inflammation
US5376633A (en) * 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
US6017880A (en) * 1994-03-09 2000-01-25 Amgen Inc. Inhibition of retrovirus infection
US5633227A (en) * 1994-09-12 1997-05-27 Miles, Inc. Secretory leukocyte protease inhibitor as an inhibitor of tryptase
US5780440A (en) * 1996-06-17 1998-07-14 Protease Sciences Inc. Treatment of pulmonary disease with protease inhibitors
US20010006939A1 (en) 1997-10-03 2001-07-05 Ralph W. Niven Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
WO1999043352A1 (fr) * 1998-02-24 1999-09-02 Fujisawa Pharmaceutical Co., Ltd. Moyens preventifs/remedes contre le vieillissement de la peau

Also Published As

Publication number Publication date
JP4610832B2 (ja) 2011-01-12
EP1234581B1 (de) 2005-12-28
DE60025260T2 (de) 2006-08-24
EP1234581A4 (de) 2004-09-22
EP1234581A1 (de) 2002-08-28
WO2001030389A1 (fr) 2001-05-03
US6984621B1 (en) 2006-01-10
AU7957700A (en) 2001-05-08

Similar Documents

Publication Publication Date Title
ATE431358T1 (de) Peptidomimetika als protease inhibitoren
NO990548L (no) Inhibitorer for cystein-protease
DE60219068D1 (de) Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren
AU2001249670A1 (en) Substituted thiazoles and the use thereof as inhibitors of plasminogen activatorinhibitor-1
ATE214693T1 (de) Aminoguanidine und alkoxyguanidine als protease- hemmer
DE69830410D1 (de) Meta-benzamidinderivate als serinprotease-inhibitoren
HK1081196A1 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
NO20032084L (no) Skiferhydrerings-hemmende middel og fremgangsmåte for anvendelse derav
HK1046899A1 (en) Inhibitors of aspartyl protease
HK1070008A1 (en) Combination of cytochome p 450 dependent protease inhibitors
DE60130578D1 (de) Schleifstoff und polierverfahren
DE60018539D1 (de) Zinkoxid als Plasminogen-Aktivator-Inhibitoren zur äusserlichen Verwendung
DE60025260D1 (de) Verwendung des sekretorischen leukozytären Proteasehemmers für Keloide und Narben
NO20011388L (no) Hydroksamat-inneholdende cystein- og serinproteasehemmere
NO20025786L (no) Protaseinhibitorer
NO20004920D0 (no) Anvendelse av proteaseinhibitorer for behandling av hudskader
PL1616007T3 (pl) Inhibitory proteinowe proteazy i ich wykorzystanie
AU2002223316A1 (en) Detection of proteases and screening for protease inhibitors
NO20025005L (no) Proteaseinhibitorer
IL156776A0 (en) Inhibitors of cruzipain and other cysteine proteases
NO20010569D0 (no) Proteaseinhibitorer for anvendelse ved behandling av psoriasis
NO20032328L (no) Proteaseinhibitorer
GB0008866D0 (en) Chimeric polypeptide inhibitors of proteases
GB0109166D0 (en) Chimeric peptide inhibitors of proteases
DE59504633D1 (de) Verwendung von rekombinantem inhibitor aus erythrina caffra zur reinigung von serinproteasen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee